Slade heads board to develop £50m global cancer treatment research centre

Mike Slade

Mike Slade, chairman of Helical, has been announced as the chairman of a £50m appeal to build the Clinical Care and Research Centre (CCRC) at The Royal Marsden NHS Foundation Trust.

This content is only available to registered users

You must be logged in to continue

Gated access promo

Would you like to read more?

Register for free to finish this article.

Sign up now for the following benefits:

  • Four FREE articles of your choice per month
  • Breaking news, comment and analysis from industry experts as it happens
  • Choose from our portfolio of email newsletters

To access this article REGISTER NOW

Would you like print copies, app and digital replica access too? SUBSCRIBE for as little as £5 per week.

Registered users and subscribers SIGN IN here to continue